Citation:Bradley J, Paulus R, Komaki R et al 2011

From Cancer Guidelines Wiki

Citation


Bradley J, Paulus R, Komaki R et al. A randomised phase III comparison of standard dose (60Gy) v high dose (74Gy) conformal chemo-radiotherapy +/- cetuximab in Stage IIIA/B NSCLC: preliminary findings on radiation dose in RTOG 0617. Proc ASTRO 2011.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy?Dr Margot Lehman MBBS FRANZCR GDPcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy?